Liver Immunosuppression Free Trial

NCT02498977 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

116

Enrollment

OTHER

Sponsor class

Stopped Primary endpoint not reached.

Conditions

Transplantation, Liver

Interventions

GENETIC: Biomarker
DRUG: Tacrolimus, cyclosporine and/or mycophenolic acid, mycophenolate mofetil or azathioprine

Sponsor

King's College London

Collaborators

[object Object]
[object Object]